Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition

Sabine Paternot, Eric Raspé, Clément Meiller, Maxime Tarabichi, Jean‐Baptiste Assié, Frederick Libert, Myriam Remmelink, Xavier Bisteau, Patrick Pauwels, Yuna Blum, Nolwenn Le Stang, Séverine Tabone‐Eglinger, Françoise Galateau‐Sallé, Christophe Blanquart, Jan P Van Meerbeeck, Thierry Berghmans, Didier Jean, Pierre P Roger. Molecular Oncology 2024/4 https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.13351

Previous
Previous

Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction

Next
Next

The cerebrospinal fluid proteomic response to traumatic and non-traumatic acute brain injury: a prospective study.